Product Images Varenicline

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Varenicline NDC 59651-418 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

varenicline-fig1.jpg - varenicline fig1

varenicline-fig1.jpg - varenicline fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 mg Continuing Month Box Carton - varenicline fig10

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 mg Continuing Month Box Carton - varenicline fig10

This is a medication guide for Varenicline tablets, each film-coated tablet contains 1.71 mg Varenicline tartrate equivalent to 1.01 mg Varenicline free base. The recommended dosage is one 1 mg tablet in the morning and one 1 mg tablet in the evening. It is important to refer to the accompanying Medication Guide for additional information. The tablets are to be stored at 20°C to 25°C (66°F to 77°F). Distributor details: Aurobindo Pharma USA, Inc. Made in India. NDC code: 59651-418-55. This is a continuing month box with 56 tablets for your next 4 weeks' supply. Pharmacists are advised to dispense the Medication Guide separately to each patient.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 mg x 56 Tablet Continuing Pack - varenicline fig11

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 mg x 56 Tablet Continuing Pack - varenicline fig11

varenicline-fig2.jpg - varenicline fig2

varenicline-fig2.jpg - varenicline fig2

varenicline-fig3.jpg - varenicline fig3

varenicline-fig3.jpg - varenicline fig3

This is a graph showing the Continuous Abstinence Rate during Nontreatment Follow-Up for individuals using Varenicline 1mg twice daily (BID) compared to those on placebo. The x-axis represents the nontreatment follow-up duration measured in weeks while the y-axis shows the continuous abstinence rate. The data points indicate the increase in abstinence rates over time for both Varenicline and Placebo users, demonstrating the effectiveness of Varenicline in promoting continuous abstinence from smoking.*

Figure 4 - varenicline fig4

Figure 4 - varenicline fig4

This text provides a structured plan to gradually reduce smoking over a period of 12 weeks. It suggests reducing the number of cigarettes smoked each day by specific fractions in each 4-week period until reaching zero cigarettes per day by the end of the 12 weeks. The plan encourages a step-by-step approach to quitting smoking.*

Figure 5 - varenicline fig5

Figure 5 - varenicline fig5

This is a treatment plan that involves taking white tablets (0.5 mg) daily for the first three days, then taking one white tablet (0.5 mg) daily on days 4 to 7 (one in the morning and one in the evening). From day 8 until the end of treatment, a light blue tablet (1 mg) should be taken twice daily, once in the morning and once in the evening. Follow the specified instructions for each day to complete the treatment regimen effectively.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.5 mg Container Label (56 Tablets Bottle) - varenicline fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.5 mg Container Label (56 Tablets Bottle) - varenicline fig6

This text provides information about Varenicline tablets manufactured by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 100.5 mg varenicline free base. The dosage and usage instructions are available in the accompanying prescribing information. The tablets should be stored at a temperature of 20°C to 25°C (68°F to 77°F). The medication should be dispensed in a tight, child-resistant packaging. Pharmacies are advised to dispense the Medication Guide provided separately to each patient. The text also mentions that the tablets are made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.5 mg and 1 mg Tablet Starting Month Box Carton - varenicline fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.5 mg and 1 mg Tablet Starting Month Box Carton - varenicline fig7

This text contains information about Varenicline tablets, including the dosage and usage instructions for quitting smoking. It provides details on the recommended dosage for different days, storage conditions, and a note about child-resistant packaging. Aurobindo Pharma USA is mentioned as the distributor. The text also refers to the website for printing Medication Guides and includes the address for the distributor in New Jersey. Overall, it serves as a guide for patients starting a month-long Varenicline tablet treatment plan to aid in smoking cessation.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - Starting Pack - varenicline fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - Starting Pack - varenicline fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 mg Container Label (56 Tablets Bottle) - varenicline fig9

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 mg Container Label (56 Tablets Bottle) - varenicline fig9

The text provides information about varenicline tablets distributed by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 1.71g of varenicline tartrate equivalent to 1mg of varenicline free base. The dosage and usage instructions can be found in the accompanying prescribing information. The tablets should be stored in controlled room temperature conditions (56° to 86°F). The pharmacist is advised to dispense the medication guide separately to each patient. For more information, visit the Aurobindo Pharma USA, Inc. website.*

Structure - varenicline str

Structure - varenicline str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.